/People

Vikas Goyal

Investor

Partner at Longwood Fund

Cambridge, Massachusetts, United States

Kauffman Fellow · Class 17

Find your path to Vikas

Sign up to see every warm intro you have to Vikas

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Vikas. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Vikas Goyal left investing to run Pandion, leading partnerships, an IPO and Merck’s $1.85B acquisition; early backer of computational drug discovery who argues experimental data, not algorithms, is AI’s bottleneck.

Contact· self-published, not guessed

Invests in

AI & Machine LearningBiotechHealthtechMedical Devices

Investments

Board seats

Morphic TherapeuticsNimbus TherapeuticsPandionRiver Vision DevelopmentSpero Therapeutics

Investor

CalciMedicaMorphic TherapeuticPandion TherapeuticsSpero Therapeutics

Sources: the firm's website · curated public sources.

Colleagues at Longwood Fund

Network1

Investors connected to Vikas in public investor directories — a warm-intro map.

Frequently asked questions

Who is Vikas Goyal?
Vikas Goyal left investing to run Pandion, leading partnerships, an IPO and Merck’s $1.85B acquisition; early backer of computational drug discovery who argues experimental data, not algorithms, is AI’s bottleneck.
Where does Vikas Goyal work?
Vikas Goyal is Partner at Longwood Fund.
What does Vikas Goyal invest in?
Vikas Goyal invests in AI & Machine Learning, Biotech, Healthtech, Medical Devices.
What boards does Vikas Goyal sit on?
Vikas Goyal holds tracked board seats at Morphic Therapeutics, Nimbus Therapeutics, Pandion, River Vision Development, Spero Therapeutics.
What companies has Vikas Goyal invested in?
Investments tracked here include CalciMedica, Morphic Therapeutic, Pandion Therapeutics, Spero Therapeutics.

About this profile. Compiled from public sources — Longwood Fund's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights